Istari Oncology

KiraGen Bio

This biotechnology company develops gene-edited cell therapies to treat solid tumours for patients with glioblastoma and other cancers.

Stratosvir

This company develops viral immunotherapies for late-stage cancer patients to target solid tumours through systemic delivery and immune system activation.

Swarm Oncology

This biotechnology company develops personalised T cell therapies for patients with advanced solid cancers to achieve long-term remission.

Akamis Bio

This clinical-stage oncology company develops intravenously administered immunotherapies to treat solid tumours, specifically targeting patients living with colorectal cancer.

Glionova AB

Glionova AB develops orally available oncolytic small molecules to treat glioblastoma and other aggressive cancers for patients with high unmet medical needs.

Ariceum Therapeutics

This clinical-stage biotechnology company develops targeted radiopharmaceutical therapies for the diagnosis and treatment of aggressive, hard-to-treat cancers.

Xilio Therapeutics

This biotechnology company develops tumour-activated immuno-oncology therapies designed to treat patients with solid cancers while reducing systemic side effects.

Bicara Therapeutics

This biotechnology company develops dual-action biologics to treat patients with solid tumours by targeting the tumour microenvironment.